It really matters who is in the room you’re in. Two years ago Lara and I pitched at the inaugural Merck Healthcare / M Ventures W Accelerate Innovation programme run by W Group The event was fantastic. The seniority of the people in that room were impressive, and the conversations that started there became the …

Day Two of the Oxford Summer Academy for the Social Science of Health Innovation (SASHI)– The Women’s Health Revolution: Women’s and Reproductive Health Equity –held at St Hilda’s College, University of Oxford 🏛️ Great to return to Oxford for a fireside chat with Dr Emma Thornton. I talked about exciting progress on our progesterone-Callavid® clinical …

Original article here Calla Lily joins $50M program targeting antibiotic resistance A new intravaginal drug delivery platform has been selected to investigate whether localized UTI treatment can reduce the collateral effects of systemic antibiotics. Written by Bree Foster, PhD Aug 11, 2026 New approaches aim to target infections while sparing the gut microbiome. credit: istock.com/Scharvik …

It was great to attend Formulation & Delivery Europe 2026 in Basel last month – a valuable opportunity to explore the latest industry trends in drug formulation and delivery, connect with industry experts to build collaborations, and discuss the technologies shaping the future of healthcare. Innovation is moving quickly in combination products and alternative routes …

We do not believe many other London based start-ups have their own labs to be able to manufacture products, but here at Calla Lily Clinical Care, we have done exactly that. All of our Callavid® design validation and clinical trial products started their production here in London. Now that our clinical trial is underway, our …

What a way to close out Day 2 of ESHRE 2026! 🌅 We were delighted to co-host an European Society of Human Reproduction and Embryology (ESHRE) Sundowner with our brilliant partners Hertility and Impli… held on the rooftop of the Lillet Bar overlooking the Thames and the iconic London skyline. 🚠 The energy was electric …

Super excited to chair the Women’s Health Horizons DC summit on October 7 and be a panelist on “Medical Education as Health Policy: If We Don’t Teach It, We Don’t Treat It.” Everything policy and women’s health. It’s a real milestone in my life. The realization that everyone would prefer it if what I have …

It’s been an intense but very productive 42nd European Society of Human Reproduction and Embryology (ESHRE) Congress – the world’s largest gathering of professionals in reproductive medicine and embryology, held at Excel London. 🌸 So many great conversations, catch-ups and new connections forged: all united by a shared mission to improve fertility outcomes in the …

FREEDOM trial reaches 100% patient consent. Calla Lily Clinical Care is pleased to share an important milestone in our NIHR funded FREEDOM clinical trial. In less than three months since recruitment began, FREEDOM has passed its safety stopping rule, and all target patient participants are now consented. More than half of total participants have also …

We’re delighted to be featured by Technology Networks in this interview with our co-founders, Dr Lara Zibners and Thang Vo-Ta, about our Callavid® intravaginal drug delivery platform. Our first focus is progesterone delivery for threatened miscarriage and IVF– areas where the clinical need is significant, but where the patient experience has too often been overlooked. …